Cargando…

Radiomics for Response and Outcome Assessment for Non-Small Cell Lung Cancer

Routine follow-up visits and radiographic imaging are required for outcome evaluation and tumor recurrence monitoring. Yet more personalized surveillance is required in order to sufficiently address the nature of heterogeneity in nonsmall cell lung cancer and possible recurrences upon completion of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shi, Liting, He, Yaoyao, Yuan, Zilong, Benedict, Stanley, Valicenti, Richard, Qiu, Jianfeng, Rong, Yi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2018
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6048673/ https://www.ncbi.nlm.nih.gov/pubmed/29940810 http://dx.doi.org/10.1177/1533033818782788

Ejemplares similares

Converting Treatment Plans From Helical Tomotherapy to L-Shape Linac: Clinical Workflow and Dosimetric Evaluation
por: Yuan, Zilong, et al.
Publicado: (2018)

“Dose of the day” based on cone beam computed tomography and deformable image registration for lung cancer radiotherapy
por: Yuan, Zilong, et al.
Publicado: (2019)

Identifying individuals with attention‐deficit/hyperactivity disorder based on multisite resting‐state functional magnetic resonance imaging: A radiomics analysis
por: Liu, Guanlu, et al.
Publicado: (2023)

Delta-radiomics features for the prediction of patient outcomes in non–small cell lung cancer
por: Fave, Xenia, et al.
Publicado: (2017)

Uniqueness of radiomic features in non‐small cell lung cancer
por: Ge, Gary, et al.
Publicado: (2022)

Whole slide imaging-based deep learning to predict the treatment response of patients with non-small cell lung cancer
por: Pan, Yuteng, et al.
Publicado: (2023)

MRI Radiomics for Prediction of Tumor Response and Downstaging in Rectal Cancer Patients after Preoperative Chemoradiation
por: Chen, Haihui, et al.
Publicado: (2020)

A biomarker basing on radiomics for the prediction of overall survival in non–small cell lung cancer patients
por: He, Bo, et al.
Publicado: (2018)

Assessing treatment outcomes of chemoimmunotherapy in extensive-stage small cell lung cancer: an integrated clinical and radiomics approach
por: Zhao, Jie, et al.
Publicado: (2023)

Multi-phase contrast-enhanced magnetic resonance image-based radiomics-combined machine learning reveals microscopic ultra-early hepatocellular carcinoma lesions
por: Sun, Kui, et al.
Publicado: (2022)

Radiomics-based Prognosis Analysis for Non-Small Cell Lung Cancer
por: Zhang, Yucheng, et al.
Publicado: (2017)

Review of the use of radiomics to assess the risk of recurrence in early-stage non-small cell lung cancer
por: Libling, William Adam, et al.
Publicado: (2023)

Immunohistochemistry and Radiomic Features for Survival Prediction in Small Cell Lung Cancer
por: Gkika, Eleni, et al.
Publicado: (2020)

Integrating Radiomics with Genomics for Non-Small Cell Lung Cancer Survival Analysis
por: Chen, Wei, et al.
Publicado: (2022)

Stage-Specific PET Radiomic Prediction Model for the Histological Subtype Classification of Non-Small-Cell Lung Cancer
por: Ji, Yanlei, et al.
Publicado: (2021)

Development of Radiomic-Based Model to Predict Clinical Outcomes in Non-Small Cell Lung Cancer Patients Treated with Immunotherapy
por: Tankyevych, Olena, et al.
Publicado: (2022)

Development of an Immune-Pathology Informed Radiomics Model for Non-Small Cell Lung Cancer
por: Tang, Chad, et al.
Publicado: (2018)

A radiomic approach for adaptive radiotherapy in non-small cell lung cancer patients
por: Ramella, Sara, et al.
Publicado: (2018)

Exploring Response to Immunotherapy in Non-Small Cell Lung Cancer Using Delta-Radiomics
por: Barabino, Emanuele, et al.
Publicado: (2022)

FDG PET and CT radiomics in diagnosis and prognosis of non-small-cell lung cancer
por: Hannequin, Pascal, et al.
Publicado: (2022)

Phenotyping the Histopathological Subtypes of Non-Small-Cell Lung Carcinoma: How Beneficial Is Radiomics?
por: Pasini, Giovanni, et al.
Publicado: (2023)

Robustness of Radiomics in Pre-Surgical Computer Tomography of Non-Small-Cell Lung Cancer
por: Belfiore, Maria Paola, et al.
Publicado: (2022)

Lung tumor segmentation methods: Impact on the uncertainty of radiomics features for non-small cell lung cancer
por: Owens, Constance A., et al.
Publicado: (2018)

Radiomics and Delta-Radiomics Signatures to Predict Response and Survival in Patients with Non-Small-Cell Lung Cancer Treated with Immune Checkpoint Inhibitors
por: Cousin, François, et al.
Publicado: (2023)

Exploratory Study of a CT Radiomics Model for the Classification of Small Cell Lung Cancer and Non-small-Cell Lung Cancer
por: Liu, Shihe, et al.
Publicado: (2020)

Evaluating the Potential of Delta Radiomics for Assessing Tyrosine Kinase Inhibitor Treatment Response in Non-Small Cell Lung Cancer Patients
por: Wang, Ting-Wei, et al.
Publicado: (2023)

Enhancement of Radiosurgical Treatment Outcome Prediction Using MRI Radiomics in Patients with Non-Small Cell Lung Cancer Brain Metastases
por: Liao, Chien-Yi, et al.
Publicado: (2021)

Systematic Review, Meta-Analysis and Radiomics Quality Score Assessment of CT Radiomics-Based Models Predicting Tumor EGFR Mutation Status in Patients with Non-Small-Cell Lung Cancer
por: Felfli, Mehdi, et al.
Publicado: (2023)

Novel Harmonization Method for Multi-Centric Radiomic Studies in Non-Small Cell Lung Cancer
por: Bertolini, Marco, et al.
Publicado: (2022)

Inflammatory Microenvironment in Early Non-Small Cell Lung Cancer: Exploring the Predictive Value of Radiomics
por: Perrone, Mariasole, et al.
Publicado: (2022)

Prediction of CD3 T cells and CD8 T cells expression levels in non-small cell lung cancer based on radiomic features of CT images
por: Chen, Lujiao, et al.
Publicado: (2023)

CT-based radiomics in predicting pathological response in non-small cell lung cancer patients receiving neoadjuvant immunotherapy
por: Lin, Qian, et al.
Publicado: (2022)

Characterizing mechanical and medical imaging properties of polyvinyl chloride‐based tissue‐mimicking materials
por: He, Yaoyao, et al.
Publicado: (2019)

Machine Learning for Histologic Subtype Classification of Non-Small Cell Lung Cancer: A Retrospective Multicenter Radiomics Study
por: Yang, Fengchang, et al.
Publicado: (2021)

[(18)F]FDG PET Immunotherapy Radiomics Signature (iRADIOMICS) Predicts Response of Non-small-cell Lung Cancer Patients Treated with Pembrolizumab
por: Valentinuzzi, Damijan, et al.
Publicado: (2020)

Assessing the robustness of radiomics/deep learning approach in the identification of efficacy of anti–PD-1 treatment in advanced or metastatic non-small cell lung carcinoma patients
por: Ren, Qianqian, et al.
Publicado: (2022)

Multitask Learning Radiomics on Longitudinal Imaging to Predict Survival Outcomes following Risk-Adaptive Chemoradiation for Non-Small Cell Lung Cancer
por: Forouzannezhad, Parisa, et al.
Publicado: (2022)

Combined Radiomics–Clinical Model to Predict Radiotherapy Response in Inoperable Stage III and IV Non-Small-Cell Lung Cancer
por: Chen, Wenrui, et al.
Publicado: (2022)

CT-based radiomics for predicting radio-chemotherapy response and overall survival in nonsurgical esophageal carcinoma
por: Li, Chao, et al.
Publicado: (2023)

Radiomic features of primary tumor by lung cancer stage: analysis in BRAF mutated non-small cell lung cancer
por: Padole, Atul, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_4vgbetp578qgiktlsg1vt4nk63